DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,042 filers reported holding DANAHER CORPORATION in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $436,930,574 | +1.7% | 1,761,107 | -1.6% | 2.27% | +6.3% |
| Q2 2023 | $429,421,129 | -8.0% | 1,789,255 | -3.4% | 2.13% | -13.5% |
| Q1 2023 | $466,969,304 | -6.1% | 1,852,759 | -1.2% | 2.47% | -9.6% |
| Q4 2022 | $497,509,009 | +2.1% | 1,874,422 | -0.6% | 2.73% | -6.2% |
| Q3 2022 | $487,099,000 | +1.7% | 1,885,860 | -0.2% | 2.91% | +8.5% |
| Q2 2022 | $478,993,000 | -14.7% | 1,889,368 | -1.3% | 2.68% | -2.2% |
| Q1 2022 | $561,739,000 | -16.0% | 1,915,042 | -5.8% | 2.74% | -9.4% |
| Q4 2021 | $668,716,000 | +7.5% | 2,032,509 | -0.6% | 3.03% | -1.0% |
| Q3 2021 | $622,213,000 | +12.1% | 2,043,795 | -1.2% | 3.06% | +12.8% |
| Q2 2021 | $554,880,000 | +18.5% | 2,067,670 | -0.6% | 2.71% | +7.9% |
| Q1 2021 | $468,294,000 | -3.7% | 2,080,569 | -5.0% | 2.51% | -8.2% |
| Q4 2020 | $486,484,000 | +1.7% | 2,189,990 | -1.4% | 2.74% | -9.3% |
| Q3 2020 | $478,254,000 | +20.7% | 2,221,027 | -0.9% | 3.02% | +9.9% |
| Q2 2020 | $396,206,000 | +28.6% | 2,240,606 | +0.7% | 2.75% | +3.0% |
| Q1 2020 | $308,016,000 | -10.9% | 2,225,389 | -1.2% | 2.67% | +15.5% |
| Q4 2019 | $345,559,000 | +6.2% | 2,251,493 | -0.1% | 2.31% | -2.4% |
| Q3 2019 | $325,367,000 | +0.6% | 2,252,768 | -0.5% | 2.37% | +0.3% |
| Q2 2019 | $323,584,000 | +8.5% | 2,264,094 | +0.2% | 2.36% | +3.5% |
| Q1 2019 | $298,218,000 | +28.6% | 2,258,886 | +0.5% | 2.28% | +10.6% |
| Q4 2018 | $231,833,000 | -4.7% | 2,248,183 | +0.4% | 2.06% | +12.2% |
| Q3 2018 | $243,306,000 | +10.7% | 2,239,154 | +0.5% | 1.84% | +2.1% |
| Q2 2018 | $219,883,000 | +2.3% | 2,228,241 | +1.5% | 1.80% | +0.1% |
| Q1 2018 | $214,869,000 | +7.4% | 2,194,555 | +1.9% | 1.80% | +9.9% |
| Q4 2017 | $199,976,000 | +11.7% | 2,154,446 | +3.2% | 1.64% | +4.3% |
| Q3 2017 | $178,997,000 | +1.4% | 2,086,698 | -0.2% | 1.57% | -1.8% |
| Q2 2017 | $176,496,000 | -2.6% | 2,091,432 | -1.3% | 1.60% | -4.2% |
| Q1 2017 | $181,241,000 | +7.2% | 2,119,040 | -2.5% | 1.67% | +3.5% |
| Q4 2016 | $169,128,000 | -3.2% | 2,172,771 | -2.5% | 1.61% | -5.7% |
| Q3 2016 | $174,730,000 | -23.9% | 2,228,979 | -2.0% | 1.71% | -24.1% |
| Q2 2016 | $229,663,000 | +5.7% | 2,273,887 | -0.7% | 2.25% | +4.1% |
| Q1 2016 | $217,327,000 | +0.7% | 2,291,031 | -1.4% | 2.16% | +6.7% |
| Q4 2015 | $215,755,000 | +9.9% | 2,322,947 | +0.9% | 2.02% | +6.2% |
| Q3 2015 | $196,252,000 | -0.8% | 2,303,158 | -0.3% | 1.90% | +11.5% |
| Q2 2015 | $197,810,000 | -3.0% | 2,311,136 | -3.8% | 1.71% | -0.1% |
| Q1 2015 | $203,906,000 | -1.3% | 2,401,725 | -0.4% | 1.71% | +2.6% |
| Q4 2014 | $206,627,000 | +12.2% | 2,410,765 | -0.5% | 1.67% | +10.3% |
| Q3 2014 | $184,135,000 | -2.2% | 2,423,463 | +1.3% | 1.51% | +1.4% |
| Q2 2014 | $188,363,000 | +6.1% | 2,392,514 | +1.1% | 1.49% | +3.0% |
| Q1 2014 | $177,516,000 | +0.1% | 2,366,875 | +3.1% | 1.45% | +1.1% |
| Q4 2013 | $177,263,000 | +11.5% | 2,296,155 | +0.1% | 1.43% | +4.8% |
| Q3 2013 | $158,976,000 | +10.8% | 2,293,366 | +1.2% | 1.36% | +2.0% |
| Q2 2013 | $143,505,000 | – | 2,267,063 | – | 1.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |